Literature DB >> 23011041

Reversal of sarcopenia predicts survival after a transjugular intrahepatic portosystemic stent.

Cynthia Tsien1, Shetal N Shah, Arthur J McCullough, Srinivasan Dasarathy.   

Abstract

BACKGROUND: Sarcopenia is the most frequent complication of cirrhosis. A transjugular intrahepatic portosystemic stent (TIPS) lowers portal pressure in cirrhosis and alters the body composition. Changes in the skeletal muscle area and adipose tissue volume were quantified by computed tomography (CT) before and after TIPS.
MATERIALS AND METHODS: Fifty-seven consecutive cirrhotics who had a CT scan before and after TIPS were studied. Simultaneous age-matched, sex-matched, Child's score-matched, and Model for End-Stage Liver Disease score-matched cirrhotics (n=32) who did not undergo TIPS comprised the disease control and 57 healthy individuals who had undergone CT abdomen comprised the healthy control population. Muscle area and fat volume were obtained at the mid-L4 vertebra level on the CT scans.
RESULTS: Patients (mean age 55.5±8.1 years) were followed up for a mean of 13.5±11.9 months following TIPS. Total psoas and paraspinal muscle area increased significantly (P<0.0001) after TIPS (from 22.8±0.9 to 25.1±0.9 cm and 54.5±1.3 to 57.9±1.5 cm, respectively). After TIPS, muscle area increased in 41 patients but remained unchanged or decreased in 16 patients. Post-TIPS visceral fat volume decreased significantly (47.7±4.1 to 40.5±3.4 cm; P<0.001). Failure to reverse sarcopenia after TIPS was accompanied by higher (P=0.007) mortality (43.5%) compared with patients in whom the total muscle area increased (9.8%). On multivariate analysis, predictors of reversal of sarcopenia after TIPS included male sex and lower pre-TIPS muscle area. Cirrhotic patients who did not undergo TIPS showed no change in the mean muscle area over 13.1±1.3 months.
CONCLUSION: TIPS reverses sarcopenia in cirrhotic patients. Failure to improve muscle area after TIPS was accompanied by a higher mortality.

Entities:  

Mesh:

Year:  2013        PMID: 23011041     DOI: 10.1097/MEG.0b013e328359a759

Source DB:  PubMed          Journal:  Eur J Gastroenterol Hepatol        ISSN: 0954-691X            Impact factor:   2.566


  56 in total

1.  ESPEN guideline on clinical nutrition in liver disease.

Authors:  Mathias Plauth; William Bernal; Srinivasan Dasarathy; Manuela Merli; Lindsay D Plank; Tatjana Schütz; Stephan C Bischoff
Journal:  Clin Nutr       Date:  2019-01-16       Impact factor: 7.324

Review 2.  Sarcopenia in Alcoholic Liver Disease: Clinical and Molecular Advances.

Authors:  Jaividhya Dasarathy; Arthur J McCullough; Srinivasan Dasarathy
Journal:  Alcohol Clin Exp Res       Date:  2017-07-11       Impact factor: 3.455

3.  Editorial: sarcopenia in liver transplantation-our weakest patients may need the strongest push.

Authors:  Nikhilesh Mazumder; Mary Rinella
Journal:  Aliment Pharmacol Ther       Date:  2019-04       Impact factor: 8.171

4.  Hepatobiliary Quiz Answers - 18 (2016).

Authors:  Sahaj Rathi; Radha K Dhiman
Journal:  J Clin Exp Hepatol       Date:  2016-07-25

5.  Post-liver transplantation sarcopenia in cirrhosis: a prospective evaluation.

Authors:  Cynthia Tsien; Ari Garber; Arvind Narayanan; Shetal N Shah; David Barnes; Bijan Eghtesad; John Fung; Arthur J McCullough; Srinivasan Dasarathy
Journal:  J Gastroenterol Hepatol       Date:  2014-06       Impact factor: 4.029

Review 6.  Nutrition and Muscle in Cirrhosis.

Authors:  Anil C Anand
Journal:  J Clin Exp Hepatol       Date:  2017-11-08

7.  Skeletal Muscle Metrics on Clinical 18F-FDG PET/CT Predict Health Outcomes in Patients with Sarcoma.

Authors:  Brent Foster; Robert D Boutin; Leon Lenchik; David Gedeon; Yu Liu; Vinay Nittur; Ramsey D Badawi; Chin-Shang Li; Robert J Canter; Abhijit J Chaudhari
Journal:  J Nat Sci       Date:  2018

8.  Exercise and physical activity in cirrhosis: opportunities or perils.

Authors:  Annette Bellar; Nicole Welch; Srinivasan Dasarathy
Journal:  J Appl Physiol (1985)       Date:  2020-04-02

Review 9.  Cause and management of muscle wasting in chronic liver disease.

Authors:  Srinivasan Dasarathy
Journal:  Curr Opin Gastroenterol       Date:  2016-05       Impact factor: 3.287

10.  Sarcopenia and a physiologically low respiratory quotient in patients with cirrhosis: a prospective controlled study.

Authors:  Cathy Glass; Peggy Hipskind; Cynthia Tsien; Steven K Malin; Takhar Kasumov; Shetal N Shah; John P Kirwan; Srinivasan Dasarathy
Journal:  J Appl Physiol (1985)       Date:  2013-01-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.